Tag: domestic financing

  • Spotlight- Ikechukwu Ofuani: A Master of Government Relations, Public Policy & Public-Private Partnerships

    Spotlight- Ikechukwu Ofuani: A Master of Government Relations, Public Policy & Public-Private Partnerships

    Ikechukwu Sylvester Ofuani, LLB, BL, MPA, DPO (Ghana), is a distinguished lawyer, government affairs strategist, and public policy leader whose career spans more than 18 years across Africa, the United Kingdom, and Ireland. Renowned for his expertise in government relations, regulatory affairs, stakeholder engagement, and policy advocacy, he has built a reputation as one of the leading voices shaping the intersection of public policy, corporate strategy, and development across Sub-Saharan Africa.

    With professional experience cutting across healthcare, MedTech, FMCG, international trade, development, corporate communications, and public-private partnerships, Ikechukwu has consistently demonstrated the ability to navigate complex regulatory environments while fostering strategic collaboration between governments, private institutions, multilateral organisations, and civil society stakeholders.

    Over the years, he has held senior leadership roles at organisations including Policy Vault Africa, Johnson & Johnson, Procter & Gamble, and the National Identity Management Commission project. In these capacities, he has led high-level engagements with governments, regulators, trade associations, development institutions, and international stakeholders, helping organisations shape policy ecosystems, strengthen institutional relationships, and drive sustainable impact.

    A significant part of his professional journey was spent at Johnson & Johnson, where he served as Director of Government Affairs and Policy for West and Central Africa. In that role, he led health system strengthening strategies and coordinated complex partnerships involving governments, donor agencies, regulatory institutions, and healthcare stakeholders across the region. His work focused on policy reform, regulatory harmonisation, strategic communications, grants management, and advocacy initiatives designed to strengthen healthcare delivery systems.

    Ikechukwu also played a strategic role in regional health diplomacy and pandemic preparedness. As one of Johnson & Johnson’s focal persons for African Union engagements on Ebola vaccines and pandemic preparedness, he coordinated engagements involving access teams, regulatory experts, medical affairs specialists, and global public health stakeholders. During the COVID-19 pandemic, he supported vaccine deployment efforts in Nigeria, Ghana, and Cameroon, and contributed to initiatives to address vaccine hesitancy and improve uptake across African countries.

    His contributions to Africa’s healthcare policy ecosystem have attracted continental recognition. He has publicly represented Johnson & Johnson as Director of Worldwide Government Affairs and Policy for West and Central Africa and has participated in high-level conversations on strengthening health regulatory systems, including at the U.S.-Africa Business Summit.

    Beyond multinational corporate leadership, Ikechukwu has also distinguished himself in the advisory and policy consulting space. He currently co-leads PV Advisors and Policy Vault Africa, a policy and government affairs advisory platform that supports organisations navigating Africa’s complex regulatory and stakeholder landscape. Through the platform, he provides strategic guidance to clients across sectors, helping them engage effectively with governments, regulators, policymakers, and development institutions.

    Under his leadership, Policy Vault Africa has contributed to broader governance and institutional reform conversations across the continent. One notable example is the organisation’s engagement with Nigeria’s Ministry of Budget and National Planning on policy digitisation and the preservation of institutional memory. The initiative seeks to improve transparency, accessibility, and the preservation of authentic policy documents for governments, researchers, private-sector actors, and citizens. Ikechukwu has consistently advocated the importance of accessible and credible policy information as a foundation for informed decision-making and long-term development planning.

    Another defining area of his impact has been public health advocacy and child survival initiatives. Ikechukwu currently serves as Project Lead of the SARMAAN Advocacy Team, where he is helping reposition SARMAAN II from a donor-supported intervention into a nationally owned and sustainably financed public health priority. Through strategic advocacy, communications, stakeholder engagement, and sustainability planning, he is supporting efforts to integrate child survival interventions into Nigeria’s broader healthcare policy architecture. His work places strong emphasis on domestic financing, institutional ownership, and building trust among governments, implementing partners, and local communities.

    His ability to transform policy conversations into measurable outcomes is further evident in his work on health system-strengthening partnerships. While at Johnson & Johnson, he successfully secured a ₦300 million healthcare partnership with Kebbi State focused on improving healthcare infrastructure across oncology, mental health, and immunology. The initiative reportedly led to the identification and treatment of over 200 indigent patients and became a model replicated in additional states.

    Prior to his healthcare and advisory engagements, Ikechukwu also recorded significant achievements in trade facilitation and investment enablement during his time at Procter & Gamble Nigeria. There, he led strategic engagements with regulatory agencies and government institutions across West Africa, facilitating multimillion-dollar investment approvals, securing customs fast-track arrangements, and supporting major industrial projects. Among his notable contributions was the coordination of government-facing engagements surrounding the commissioning of a US$300 million diaper manufacturing plant in Agbara, Ogun State, attended by senior government officials including the Vice President of Nigeria.

    Beyond his corporate and policy engagements, Ikechukwu is also committed to social impact and advocacy. He currently sits on the board of Stockport Advocacy in the United Kingdom, an organisation focused on advocating for children with learning disabilities. His leadership and contributions to public-private partnerships and Africa-focused policy engagement have earned him recognition, including being named a 2024 GCC Powerlist awardee.

    What distinguishes Ikechukwu Sylvester Ofuani is his rare combination of legal training, policy expertise, stakeholder intelligence, and strategic leadership. Across multinational corporations, advisory platforms, donor-supported programmes, and government-facing initiatives, he has built a career centred on helping institutions navigate complexity, build trust with governments, and translate policy engagement into tangible social and commercial impact.

    His journey reflects the growing importance of strategic government relations and policy leadership in shaping Africa’s development trajectory. Through his work, Ikechukwu continues to demonstrate that effective engagement between the public and private sectors remains one of the most powerful tools for driving sustainable growth, institutional reform, and transformational impact across the continent.

  • African health ministers call for urgent action as progress against malaria stalls

    African health ministers call for urgent action as progress against malaria stalls

    Over the past two decades, the gains made in malaria control and elimination have led to about 2.2 billion cases and 12.7 million deaths averted thanks to scaled up malaria control efforts

    Progress against malaria in the African region has significantly slowed down, with cases declining by just 5% since 2015 and mortality by 16%, far short of the 75% reduction target that was to be achieved by 2025. Without intensified efforts, the region risks missing the 2030 targets under the Global Technical Strategy for malaria.

    The Global Technical Strategy for malaria 2016–2030, adopted in 2015, sets the target of reducing global malaria incidence and mortality rates by at least 90% by 2030.

    Weak health systems characterized by poor and delayed access to quality health services; impacts of conflicts and natural disasters; inadequate domestic financing; and climate change are among the factors hindering progress against malaria. Widespread insecticide resistance; and resistance to diagnostics and antimalarial drugs; as well as insufficient coordination also contribute to the stagnation.

    Few African governments have met their commitments to increase domestic financing to end malaria due to constrained economic environment and conflicting national priorities. In 2023, a total of US$4 billion was invested globally in the malaria response, compared with the US$8.3 billion needed. About 63% of malaria funding came from international sources. Recent funding cuts and the global funding shifts could further undermine the gains made so far but present an opportunity for rethinking the financing model of malaria programmes.  

    Meeting for the Seventy-fifth session of the World Health Organisation (WHO) Regional Committee for Africa in Lusaka, Zambia, from 25 to 27 August 2025, African health ministers called for urgent action to accelerate malaria prevention and control.

    The health ministers agreed on a range of urgent actions including strengthening local institutional capacity to drive health system resilience, training and retaining skilled health workers, including community health workers; strengthening supply chains for malaria commodities through pooled procurement systems and local manufacturing; improving the use of data analytics to sustain and expand coverage in cost-effective interventions including the roll out of malaria vaccination; as well as increasing domestic funding, coordination and accountability of Governments and stakeholders .

    “Progress has been made, but it is not nearly enough. Cases and deaths are not falling fast enough. We must do more, and we must do it faster,” said Dr Mohamed Janabi, WHO Regional Director for Africa. “Ending malaria is not only about saving lives. It is about unlocking human potential, driving economic growth and securing Africa’s stability and future. Together, governments, partners, civil society and communities can consign malaria to the history books.”

    Over the past two decades, the gains made in malaria control and elimination have led to about 2.2 billion cases and 12.7 million deaths averted thanks to scaled-up malaria control efforts.

    There have been increases in the coverage of malaria control measures. Insecticide-treated net use rates increased from 46% in 2021 to 59% in 2023; the number of children accessing seasonal malaria chemoprevention increased from 200,000 in 2012 to 53 million in 2023 across 18 countries, and by July 2025, close to 6 million children had received malaria vaccines in 20 countries.

    We are also seeing some progress in malaria elimination, and since 2015, two countries in the Region, Algeria in 2019 and Cabo Verde in 2024, have been certified malaria-free.

    Rwanda and Sao Tome and Principe are on track to meet the 2025 targets, Rwanda for reducing case incidence, and Sao Tome and Principe for lowering mortality, underscoring that tailored, data-driven strategies can deliver lifesaving results.

    With sustained commitment, it is possible to end malaria.